Archbishop Desmond Tutu’s life was a gift. Help continue his influence on awareness, early diagnosis and effective treatment of prostate cancer by supporting the endowment in his name: alumni.uct.ac.za/news/2021/desm…

The lives of People cannot come second to the dollar. Winnie Byanyima Joseph E. Stiglitz Helen Clark Mark Malloch-Brown Nzinga Qunta Card Peter K. Turkson The next Access to Medicine Foundation in Nov will uncover whether any #pharma companies have learnt from this pandemic in #access2meds to put people first.

linkedin.com/posts/activity…

Recently spoke with ⁦Cassie McGrath⁩ about our new collaboration linkedin.com/posts/activity…

Making HIV care equitable: an interview with Dr. Harald Nusser. idse.net/HIV-AIDS-STIs/… Gilead Sciences Harald Nusser #HIV

Brilliant m.faz.net/aktuell/wissen…

This #WorldNTDDay, we continue to honor our decades-long commitment to helping those most vulnerable to visceral leishmaniasis (VL) receive treatment to combat one of the deadliest parasitic diseases. With World Health Organization (WHO), we've helped reduce VL's prevalence in India & Bangladesh.

linkedin.com/posts/activity…

We’re proud to announce our intention to support the Getting to Zero CM Deaths program in Eswatini with the Eswatini Ministry of Health, the Mycotic Diseases Branch at the U.S. Centers for Disease Control, Integral Global Consulting and Georgetown University.

linkedin.com/posts/activity…

The latest advances from our person-centric HIV treatment research program are featured in today’s #CROI2023 press conference.  gilead.inc/3kiNz5x

Johanna Mercier, Chief Commercial Officer, was a keynote speaker at Reuters’ Pharma USA today. Read her perspective on Gilead’s long legacy of working toward ensuring our therapies reach those who could benefit and our ongoing work to break down barriers to access.

Approximately 5% of people living with chronic #HBV are also living with #HDV. That's 12- 60 million people who may be living with #HepD globally. At Gilead, we are committed to helping meet the unmet needs of people living with #HepatitisDelta.

Failing to mobilize the funding needed to achieve the targets outlined in the United Nations 2021 Political Declaration on HIV/AIDS, and sustain the impact, will lead to avoidable health, social and economic costs. The #TripleDividend report explains how. 🔗bit.ly/3UEoCzh

Today, we launched our inaugural ESG Impact Report. Learn how we’re advancing our mission to create a healthier world while benefiting our people, the communities we support and our planet.

Hepatitis Delta, also known as #HDV, is the most severe form of hepatitis – but how do you acquire it? Learn more about the difference between HDV co-infection and superinfection.

Today, #EarthDay, we join the global community in celebrating our planet and the efforts being made to safeguard it. At Gilead, we understand the connection between our climate and human health, and we're firmly committed to protecting both.

In our first quarter, we built on the momentum we saw in 2022 and made important progress in our work to make the world a healthier place for all people. We look forward to growth and continued advancements across HIV, oncology and our other therapeutic areas. #earnings

How is AI contributing to the climate crisis? …ea01.safelinks.protection.outlook.com/?url=https%3A%…

We are pleased to announce Thomas Schinecker, CEO, Roche will be attending the #H20summit at the United Nations, Geneva on 21 June. He will be participating in our first fireside discussion! #G7 #G20 #H20summit23 #health4all #sustainablefinance